Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. (MRTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · MRTX · as of Jun 9, 2026
Activity summary
Buy transactions
5
P-Purchase only
Sell transactions
11
12 Months
Buy/Sell ratio
0.45
Buy/Sell (by trades)
Overall sentiment
Mirati Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
MRTX insider buying and selling by quarter
MRTX insider selling · MRTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
MRTX executive sell shares · MRTX board member insider trading · MRTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 23, 2024 | Boxer Capital, LLC other: See remarks | Other | 30,518 | $31 | Form 4 |
| Jan 23, 2024 | Sharp Shalini Director | Other | 4,162 | $241K | Form 4 |
| Jan 23, 2024 | Sharp Shalini Director | Other | 5,252 | — | Form 4 |
| Jan 23, 2024 | Sharp Shalini Director | Other | 6,808 | — | Form 4 |
| Jan 23, 2024 | Cherrington Julie M Director | Other | 4,444 | — | Form 4 |
| Jan 23, 2024 | Cherrington Julie M Director | Other | 6,808 | — | Form 4 |
| Jan 23, 2024 | Davis Aaron I. Director | Other | 43,073 | $2.50M⚡ | Form 4 |
| Jan 23, 2024 | Davis Aaron I. Director | Other | 4,444 | — | Form 4 |
| Jan 23, 2024 | Davis Aaron I. Director | Other | 6,808 | — | Form 4 |
| Jan 23, 2024 | CARTER BRUCE L A Director | Other | 6,021 | $349K | Form 4 |
| Jan 23, 2024 | CARTER BRUCE L A Director | Other | 4,444 | — | Form 4 |
| Jan 23, 2024 | CARTER BRUCE L A Director | Other | 6,808 | — | Form 4 |
| Jan 23, 2024 | Johnson Craig A Director | Other | 6,021 | $349K | Form 4 |
| Jan 23, 2024 | Johnson Craig A Director | Other | 4,444 | — | Form 4 |
| Jan 23, 2024 | Johnson Craig A Director | Other | 6,808 | — | Form 4 |
| Jan 23, 2024 | Hasnain Faheem Director | Other | 8,717 | $506K | Form 4 |
| Jan 23, 2024 | Hasnain Faheem Director | Other | 6,333 | — | Form 4 |
| Jan 23, 2024 | Hasnain Faheem Director | Other | 9,702 | — | Form 4 |
| Jan 23, 2024 | Ondrey Aaron CFO | Other | 1,302 | $76K | Form 4 |
| Jan 23, 2024 | Ondrey Aaron CFO | Other | 21,138 | — | Form 4 |
| Jan 23, 2024 | Ondrey Aaron CFO | Other | 17,021 | — | Form 4 |
| Jan 23, 2024 | Moriarty John B Chief Legal Officer | Other | 675 | $39K | Form 4 |
| Jan 23, 2024 | Moriarty John B Chief Legal Officer | Other | 71,660 | — | Form 4 |
| Jan 23, 2024 | Hickey Benjamin EVP, Chief Commercial Officer | Other | 27,801 | $1.61M⚡ | Form 4 |
| Jan 23, 2024 | Hickey Benjamin EVP, Chief Commercial Officer | Other | 72,206 | — | Form 4 |
Boxer Capital, LLC
other: See remarks
Date
Jan 23
Shares
30,518
Price
$0.00
Value
$31
Moriarty John B
Chief Legal Officer
Date
Jan 23
Shares
675
Price
$58.00
Value
$39K
Hickey Benjamin
EVP, Chief Commercial Officer
Date
Jan 23
Shares
27,801
Price
$58.00
Value
$1.61M ⚡
Hickey Benjamin
EVP, Chief Commercial Officer
Date
Jan 23
Shares
72,206
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About MRTX insider trading
MRTX insider trades
Mirati Therapeutics, Inc. (MRTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MRTX. Over the past 12 months, 0 insiders have filed transactions with the SEC. MRTX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Mirati Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
MRTX insider trading · 5 questionsThe insiders of Mirati Therapeutics, Inc. (MRTX) include executives and directors such as MRTX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026